Long Term Study of Genotropin (Somatropin) for Short Children Born Small for Gestational Age (SGA)

Status:
Completed

Trial end date:
2015-08-01

Target enrollment:

Participant gender:

To assess the long-term safety of Genotropin(somatropin) on Small for Gestational Age (SGA) without epiphyseal closing.

Phase 4

Pfizer